A recent study led by Dr Ajit
Lalvani, of the Nuffield Department of Clinical Medicine, has revealed that the
BCG vaccine may not just prevent the progression from tuberculosis infection to
an active disease, but may also prevent the contraction of infection. Dr
Lalvanic and his team conducted the ELISpot skin test to assess infection on
979 children in Istanbul
living with someone infected with TB, The results showed that 24% of the
children with a BCG scar, who had been vaccinated already, were not infected.
These results mean a great leap in progress for approaching the vaccination
against, and treatment of, TB.ARCHIVE: 2nd week MT 2005
BCG vaccine
